SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031002
Filing Date
2024-08-09
Accepted
2024-08-09 16:30:52
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 991832
2 ex3-1.htm EX-3.1 9740
3 ex31-1.htm EX-31.1 19677
4 ex31-2.htm EX-31.2 19776
5 ex32-1.htm EX-32.1 9756
6 ex3-1_001.jpg GRAPHIC 924678
7 ex3-1_002.jpg GRAPHIC 1474616
8 ex3-1_003.jpg GRAPHIC 1298006
9 ex3-1_004.jpg GRAPHIC 1475650
10 ex3-1_005.jpg GRAPHIC 1321776
11 ex3-1_006.jpg GRAPHIC 823083
12 ex3-1_007.jpg GRAPHIC 463622
13 ex3-1_008.jpg GRAPHIC 585387
14 ex3-1_009.jpg GRAPHIC 374464
15 ex3-1_010.jpg GRAPHIC 94859
16 ex3-1_011.jpg GRAPHIC 826721
17 ex3-1_012.jpg GRAPHIC 101184
  Complete submission text file 0001493152-24-031002.txt   18132269

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE zvsa-20240630.xsd EX-101.SCH 37702
19 XBRL CALCULATION FILE zvsa-20240630_cal.xml EX-101.CAL 43119
20 XBRL DEFINITION FILE zvsa-20240630_def.xml EX-101.DEF 141870
21 XBRL LABEL FILE zvsa-20240630_lab.xml EX-101.LAB 354217
22 XBRL PRESENTATION FILE zvsa-20240630_pre.xml EX-101.PRE 259352
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 658033
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41184 | Film No.: 241193291
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)